# Vescell(TM) for the Treatment of Patients With Severe Anginal Syndrome With or Without Heart Failure

> **NCT00416663** · PHASE1,PHASE2 · UNKNOWN · sponsor: **TheraVitae Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- Angina Pectoris

## Interventions

- **PROCEDURE:** Intracoronary administration of autologous ACPs

## Key facts

- **NCT ID:** NCT00416663
- **Lead sponsor:** TheraVitae Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-08
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2007-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00416663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00416663, "Vescell(TM) for the Treatment of Patients With Severe Anginal Syndrome With or Without Heart Failure". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00416663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*